咪格列唑结构式
|
常用名 | 咪格列唑 | 英文名 | Midaglizole |
|---|---|---|---|---|
| CAS号 | 66529-17-7 | 分子量 | 251.32600 | |
| 密度 | 1.14g/cm3 | 沸点 | 460ºC at 760 mmHg | |
| 分子式 | C16H17N3 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | 232ºC |
咪格列唑用途米达唑((±)-DG5128游离碱,DG5128游离碱)是一种有效的α2-肾上腺素受体拮抗剂。米达唑是一种降血糖剂。米达唑可增加血压并降低体内血糖水平[1][2][3]。 |
| 中文名 | 咪格列唑 |
|---|---|
| 英文名 | Midaglizole |
| 英文别名 | 更多 |
| 描述 | 米达唑((±)-DG5128游离碱,DG5128游离碱)是一种有效的α2-肾上腺素受体拮抗剂。米达唑是一种降血糖剂。米达唑可增加血压并降低体内血糖水平[1][2][3]。 |
|---|---|
| 相关类别 | |
| 体外研究 | 对于大鼠胰岛和MIN6β细胞系,咪达唑分别以200 nM和24µM的EC50值刺激胰岛素释放[3]。 |
| 体内研究 | 咪达唑(3.30 mg/kg;静脉注射)会增加大鼠血压[1]。米达唑(0.2、1、2 mg/kg;输注)可降低血糖水平,单位为天[2]。动物模型:290-450 g,雄性Wistar大鼠[1]剂量:3.30 mg/kg给药:静脉注射。结果:在3.30 mg/kg时,血压分别升高27和64 mmHg。动物模型:狗[2]剂量:0.2、1、2 mg/kg给药:胰十二指肠动脉高压输注结果:通过刺激胰岛释放胰岛素降低血糖水平。 |
| 参考文献 |
| 密度 | 1.14g/cm3 |
|---|---|
| 沸点 | 460ºC at 760 mmHg |
| 分子式 | C16H17N3 |
| 分子量 | 251.32600 |
| 闪点 | 232ºC |
| 精确质量 | 251.14200 |
| PSA | 37.28000 |
| LogP | 2.36970 |
| InChIKey | TYZQFNOLWJGHRZ-UHFFFAOYSA-N |
| SMILES | c1ccc(C(CC2=NCCN2)c2ccccn2)cc1 |
| 折射率 | 1.629 |
| 海关编码 | 2933990090 |
|---|
|
~97%
咪格列唑 66529-17-7 |
| 文献:Ishikawa Chemical and pharmaceutical bulletin, 1980 , vol. 28, # 5 p. 1394 - 1402 |
|
~%
咪格列唑 66529-17-7 |
| 文献:Ishikawa Chemical and pharmaceutical bulletin, 1980 , vol. 28, # 5 p. 1394 - 1402 |
|
~%
咪格列唑 66529-17-7 |
| 文献:Ishikawa Chemical and pharmaceutical bulletin, 1980 , vol. 28, # 5 p. 1394 - 1402 |
|
~67%
咪格列唑 66529-17-7 |
| 文献:Ishikawa Chemical and pharmaceutical bulletin, 1980 , vol. 28, # 5 p. 1394 - 1402 |
|
~%
咪格列唑 66529-17-7 |
| 文献:Sperber; Fricano Journal of the American Chemical Society, 1953 , vol. 75, p. 2986 |
|
~%
咪格列唑 66529-17-7 |
| 文献:Ishikawa Chemical and pharmaceutical bulletin, 1980 , vol. 28, # 5 p. 1394 - 1402 |
|
~%
咪格列唑 66529-17-7 |
| 文献:Schering Corp. Patent: US2604473 , 1950 ; |
| 海关编码 | 2933990090 |
|---|---|
| 中文概述 | 2933990090. 其他仅含氮杂原子的杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
实验名称:The glycemia values 30 minutes after glucose administration to streptozotocin rats
来源:ChEMBL
靶标:Rattus norvegicus
External Id:CHEMBL784742
|
|
实验名称:Percent of variation of glycemia value 30 mins after glucose administration by intrap...
来源:ChEMBL
靶标:Rattus norvegicus
External Id:CHEMBL781141
|
|
实验名称:Incremental glycemia values over baseline integrated over 30 min after glucose admini...
来源:ChEMBL
靶标:Rattus norvegicus
External Id:CHEMBL882788
|
|
实验名称:Rate of glucose disappearance between 5 and 30 min after glucose administration with ...
来源:ChEMBL
靶标:Rattus norvegicus
External Id:CHEMBL788882
|
|
实验名称:The rate of glucose disappearance between 5 and 30 minutes after glucose administrati...
来源:ChEMBL
靶标:Rattus norvegicus
External Id:CHEMBL789998
|
|
实验名称:The incremental glycemia values after glucose administration (0.5 g/kg iv), to rats t...
来源:ChEMBL
靶标:Rattus norvegicus
External Id:CHEMBL840504
|
| 2-[2-(2-Imidazolin-2-yl)-1-phenylethyl]pyridine |
| 2-[2-Phenyl-2-(pyridyl)]ethyl-2-imidazolin |
| 2-(4,5-dihydro-1H-imidazol-2-yl)-1-phenyl-1-[2]pyridyl-ethane |
| 4,5-Dihydro-2-[2-(2-pyridinyl)-2-phenylethyl]-1H-imidazole |
| DG-5128 |
| 2-(4,5-Dihydro-1H-imidazol-2-yl)-1-phenyl-1-[2]pyridyl-aethan |
| 2-(2-phenyl-2-(2-pyridyl))ethyl-2-imidazoline |